Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

APPY 3.38 -0.06 (-1.74%)
price chart
Next Weeks Broker Price Targets For Venaxis, Inc. (APPY)
01/29/2015 - Venaxis, Inc. was downgraded to “hold” by analysts at Craig-Hallum. Venaxis, Inc. has a 50 day moving average of 3.17 and a 200 day moving average of 2.46.
Venaxis, Inc. (NASDAQ:APPY) Impact Score At 0
Alpha One explored various online articles released on Venaxis, Inc. (NASDAQ:APPY), and it set a daily sentiment score of 0 on the company.
Venaxis Inc. APPY (US: Nasdaq)
News Venaxis Inc.APPY. Significant News Only. 03/14/16; Press Release. Venaxis Announces Termination of Proposed Transactions with Strand Life Sciences.
Venaxis, Inc. (APPY) Updated Broker Ratings
A number of investment brokers have recently updated their price targets on shares of Venaxis, Inc. (APPY). According to the latest broker reports outstanding on Friday 27th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...
Venaxis Incorporated (NASDAQ:APPY) Short Interest Increased By 6.23%  Franklin Independent
Incontact Inc, Andersons Inc, MacroGenics Inc, MGT Capital Investments Inc ...
These include Incontact Inc which is up by almost 54%, Andersons Inc whose stock price has surged by more than 30%, and MacroGenics Inc that has galloped higher by nearly 18%.
Venaxis, Inc. (APPY) Latest Broker Views  Risers & Fallers
Venaxis Inc (NASDAQ:APPY) fell 18.06% last Trade  News Oracle
Stocks to Keep Your Eyes on Neothetics Inc (NASDAQ:NEOT), Venaxis Inc (NASDAQ ...
Shares of Neothetics Inc (NASDAQ:NEOT) flew +14.58% to $1.20 at 2:06 PM EDT. The stock attained the volume of 2.06 Million shares recently versus average trading volume of 793,682.00 shares.
Latest Analyst Reports On Venaxis, Inc.
Venaxis, Inc. (Venaxis) is an in vitro diagnostic company that is focused on commercializing its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children, adolescent and young adults.
Latest Price movements of Stocks: Dynavax Technologies Corporation (NASDAQ ...
Venaxis, Inc. (NASDAQ:APPY) after beginning at $3.40, closed at $3.97 by building up +9.37% in recent trading session.
Venaxis Inc (APPY) Stock Crashes On FDA's “Not Substantially Equivalent” Response
Venaxis Inc (NASDAQ:APPY) has received "not substantially equivalent" remarks on its blood-based diagnostic test, APPY1, from the US Food and Drug Administration (FDA).
Venaxis' appendicitis test not found equivalent to standard care  Reuters
Venaxis Receives FDA "Not Substantially Equivalent" Response on ...  PR Newswire (press release)
INVESTOR ALERT: Class Action Lawsuit Against Venaxis, Inc. Announced By Glancy ...
LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of a class (the “Class”) comprising purchasers of the securities ...